Navigation Links
The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings
Date:3/6/2008

$1.39 $1.66

Diluted $0.32 $0.31 $1.17 $1.34

Weighted average common

shares outstanding:

Basic 17,566 13,393 14,497 13,366

Diluted 19,204 16,984 17,470 16,823

Consolidated Balance Sheets

(in thousands)

December 31,

2007 2006

Assets

Cash and cash equivalents $51,732 $25,491

Other current assets 68,631 58,314

Total current assets 120,363 83,805

Property and equipment, net 124,861 87,133

Other assets 22,165 19,593

Total assets $267,389 $190,531

Liabilities and stockholders' equity

Current liabilities:

Current liabilities, excluding current

maturities of long-term debt $54,401 $54,583

Current maturities of long-term debt 2,993 941

Total current liabilities 57,394 55,524

Long-term debt-less current maturities 60,577 63,587

Other long-term liabilities 19,741 17,548

Series A redeemable convertible preferred stock -- 2,725

Total Stockholders' equity 129,677 51,147

Total liabilities and stockholders' equity $267,389 $190,531

Reconciliation of Net Income to EBITDAR

(in thousands)


'/>"/>

SOURCE The Ensign Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. The Ensign Group, Inc. to Announce Third Quarter 2007 Financial Results
2. The Ensign Group, Inc. Acquires Assets of Three Previously Leased Facilities
3. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
4. The Ensign Group, Inc. Announces the Appointment of Covey C. Christensen as President of Its Flagstone Subsidiary
5. The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program
6. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
7. The Ensign Groups Year-End Conference Call Scheduled for Friday, March 7, 2008
8. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
11. Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... ... solutions for drugs, biologics and consumer health products, today welcomed the announcement by ... OPKO’s New Drug Application for a new treatment for chronic kidney disease (CKD) ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today ... management solution, as well as announced the date of its next major release. ... of contract management tasks as well as enhancements to the customer experience. ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... of it’s new program “Designing Secure Healthcare Systems” This three-day, highly interactive ... leaders from healthcare organizations with access to the tactics, techniques and practices required ...
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article ... Stem Cells Found to Release Natural Painkiller That Can Last 'For Five Weeks'" ... to the report, the new study showed that harvesting stem cell-rich bone marrow from ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... firm, announced today that Joe Williams has joined its growing California employee benefits ... HUB's differentiated service model to his clients. Mr. Williams will be joining the ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Novatus Unveils Milestone Software Release 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2
... 21 In this unstable economic,environment characterized by ... competition in the,bio/pharma marketplace, retaining your most-valued customers ... posts - from web interactions,and early warning systems ... toward,defining the superior customer experience. , ...
... invited to participate with U.S. Secretary of Health, Michael Leavitt, in ... ... Salt Lake City (Vocus) November 20, 2008 -- MediConnect CEO, ... Health, Michael Leavitt, in the 2008 National Summit on Personalized Health ...
... and Extremely Intuitive to Navigate, Making Shopping for Safety Products Easier ... ... 2008 -- Conney Safety Products is proud to announce that their ... state-of-the-art technology. The new website is faster, more efficient and features ...
... D. and Catherine T. MacArthur Foundation is creating a new ... and opportunities posed by our aging society. In the ... an aging society, one feature of which is that those ... Although the nation will become increasingly gray in subsequent decades, ...
... returned positive results in review of national program , , ... detects 40 percent of cancers and should be carefully ... researchers. , They studied 106,000 people, aged 60 to ... program was in identifying unrecognized disease. Half the people ...
... (NMQF) today applauded the American Medical Association,s recent decision to ... physician and patient advocates to join the Forum in encouraging ... , "Physicians and lawyers -- even politicians -- ... Chief Executive Officer of the Forum. "It,s long past time ...
Cached Medicine News:Health News:Creating Brand Advocates by Delivering the Superior Total Customer Experience 2Health News:MediConnect Participates in 2008 National Health Summit 2Health News:Conney Safety Products, Leader in Safety Equipment and Supplies, Launches New Website 2Health News:New MacArthur network to examine impact of aging society 2Health News:Colorectal Cancer Screens Detect Unrecognized Disease 2Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2
(Date:8/3/2015)... ZIONA, Israel , August 3, 2015 ... BVXV) today announced it received the statistical analysis of results ... (M-001), administered in the BVX-005 phase II trial which took ... strains which did not exist at the time of the ... strain that caused the epidemic in the United ...
(Date:8/3/2015)... 3, 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... an exclusive licensing agreement to develop and commercialize multiple ... Limited, a holding company for premier antibody development and ... Under the terms of the agreement, Sorrento ... for the North American, European and Japanese market. Each ...
(Date:7/31/2015)... 31, 2015  Physicians and payers alone do ... market. Patients are better informed and getting increasingly ... therapies. This shift in power is reshaping the ... patient-focused marketing. As part of this ... it,s important to educate, communicate and engage patients ...
Breaking Medicine Technology:Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2
This multiple-function instrument allows the surgeon to grasp, coagulate, and transect tissue with a single instrument, eliminating the need for multiple instruments and, in some procedures, costly l...
... The proprietary Ambient Noise Reduction ... out anaverage of 75% of distracting ... acoustic canceling effect is different from ... out some portions of body sounds ...
... Afinion AS100 Analyzer ... on-the-spot testing, regardless of ... test was launched in ... CRP test in May ...
... Virion\Serions comprehensive line of ELISA Classic serology ... viral, and fungal pathogens with rapid, standardized ... IgA antibodies. All of the ELISA antigens ... in their own laboratories under the control ...
Medicine Products: